Laparoscopic Imaging System
Lung cancer, prostate cancer, colorectal cancer
Conceptual / Early DevelopmentActive
Key Facts
Indication
Lung cancer, prostate cancer, colorectal cancer
Phase
Conceptual / Early Development
Status
Active
Company
About SurgVision
SurgVision is a clinical-stage medical device company focused on improving oncological surgery and interventions through advanced fluorescence imaging. Its core commercial asset is the EXPLORER AIR® II system, cleared by the US FDA for ICG-based perfusion imaging and for use with pafolacianine, alongside a CE mark in the EU. The company possesses a robust pipeline of imaging systems and targeted agents for open, minimally invasive, and interventional procedures, aiming to address the critical unmet need of incomplete tumor resection which occurs in up to 40% of surgeries.
View full company profile